Abstract
An aldosterone-producing adenoma (APA) was associated with chronic renal failure. Following treatment with Trilostane (a 3β-hydroxysteroid dehydrogenase inhibitor), furosemide and continuous ambulatory peritoneal dialysis (CAPD), a left adrenal adenoma was successfully removed. This patient, still being treated with CAPD, is a unique example of primary aldosteronism without showing suppressed plasma renin activity.
Similar content being viewed by others
References
Beastall, G. H., Ratcliffe, W. A., Thomson, M., Semple, C. G.: Trilostane interference with steroid assays.Lancet, 1, 727 (1981).
Council on scientific affairs: Continuous ambulatory peritoneal dialysis.JAMA, 248, 2340 (1982).
Ferriss, J. B., Beevers, D. G., Brown, J. J., Davies, D. L., Fraser, A. F., Mason, P., Neville, A. M., Robertson, J. I. S.: Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronism.Am. Heart J., 95, 375 (1978).
Franklin, S. S.: Hypertension. In: Gonick, H. C. (Ed.): Current Nephrology, Vol. 1. Pinecliff Medical Publishing Co., Pacific Palisades, California 1977, p. 203.
Gravas, H., Oliver, J. A., Cannon, P. J.: Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.Ann. Rev. Med., 27, 485 (1976).
Hartroft, P. M.: The juxtaglomerular complex.Ann. Rev. Med., 117, 113 (1966).
Hollenberg, N. K.: The physiology of the renal circulation. In: Black, D., Jones, N. F. (eds): Renal Disease, 4th edition. Blackwell Scientific Publications, Oxford-London-Edinburgh-Melbourne 1979, p. 30.
Kawasaki, T., Omae, T., Tanaka, K., Matsunaga, M., Emoto, K.: Remission of recurrent hyperaldosteronism resulting from subtotal adrenalectomy of adenomatous hyperplastic adrenal glands.J. Clin. Endocrinol. Metab., 33, 474 (1971).
Komanicky, P., Spark, R. F., Melby, J. C.: Treatment of Cushing's syndrome with Trilostane (WIN 24,540), an inhibitor of adrenal biosynthesis.J. Clin. Endocrinol. Metab., 47, 1042 (1978).
Mc Kenna, J. J., Island, D. P., Nicholson, W. E., Liddle, G. W.: The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa.Endocrinology, 103, 1411 (1978).
Neville, A. M., O'Hara, M. J.: Hyperaldosteronism and related syndrome of mineralocorticoid excess. In: Neville, A. M., O'Hara, M. J. (eds): The Human Adrenal Cortex. Pathology and Biology — An Integrated Approach. Springer-Verlag, Berlin-Heidelberg-New York 1982, p. 202.
Nolph, K. D., Sorkin, M., Rubin, J., Arfania, D., Prowant, B., Fruto, L., Kennedy, D.: Continuous peritoneal dialysis.JAMA, 248, 2340 (1982).
Obana, M., Hayakawa, Y., Higashi, F., Irimajiri, S., Fujimori, I., Suito, T., Saito, T., Fukuda, J., Kondo, K., Saruta, T., Kato, E.: A case of primary aldosteronism with chronic renal failure (in Japanese).Jap. J. Nephrol., 22, 50 (1980).
Popovich, R. P., Moncrief, J. W., Nolph, K. D., Ghods, A. J., Twardowski, Z. J., Pyle, W. K.: Continuous ambulatory peritoneal dialysis.Ann. Intern. Med., 88, 449 (1978).
Potts, G. C., Creange, J. E., Harding, H. R., Schane, H. P.: Trilostane, an orally active inhibitor of steroid biosynthesis.Steroids, 32, 257 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakada, T., Kimura, M. Primary aldosteronism associated with chronic renal failure. International Urology and Nephrology 16, 165–173 (1984). https://doi.org/10.1007/BF02082781
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082781